Telomerase reverse transcriptase-based therapies Grant US-11529396-B2 United States of America 20 Dec 2022
TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES Application EP-3978031-A1 European Patent Office 06 Apr 2022
TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES Application EP-3848056-A1 European Patent Office 14 Jul 2021
TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES Application EP-3485914-A1 European Patent Office 22 May 2019